DNMT3A and metabolic dysfunction-associated steatotic liver disease: However, this FGF15/19-SHP-DNMT3A axis is likely dysregulated in NAFLD patients and obese mice, which contributes to decreased DNA methylation at the lipogenic genes and increased gene expression31–34.